SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-032576
Filing Date
2024-04-12
Accepted
2024-04-12 16:30:07
Documents
11
Period of Report
2024-04-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0203662-6k_neurosense.htm 6-K 26564
2 FORM OF PRE-FUNDED WARRANT ea020366201ex4-1_neurosense.htm EX-4.1 84354
3 OPINION OF GOLDFARB GROSS SELIGMAN & CO ea020366201ex5-1_neurosense.htm EX-5.1 8347
4 OPINION OF GREENBERG TRAURIG P.A ea020366201ex5-2_neurosense.htm EX-5.2 14266
5 PLACEMENT AGENT AGREEMENT, DATED AS OF APRIL 10, 2024, BY AND BETWEEN NEUROSENSE ea020366201ex10-1_neurosense.htm EX-10.1 46706
6 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF APRIL 10, 2024, BY AND BETWEE ea020366201ex10-2_neurosense.htm EX-10.2 233024
7 FORM OF ORDINARY WARRANT ea020366201ex10-3_neurosense.htm EX-10.3 93078
8 PRESS RELEASE, DATED APRIL 11, 2024 ea020366201ex99-1_neurosense.htm EX-99.1 11012
9 GRAPHIC ex5-1_001.jpg GRAPHIC 11896
10 GRAPHIC ex5-1_002.jpg GRAPHIC 41424
11 GRAPHIC ex5-2_001.jpg GRAPHIC 2870
  Complete submission text file 0001213900-24-032576.txt   596242
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41084 | Film No.: 24841856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)